Conference Description

September 9, 2006
Doubletree Chicago - Arlington Heights
75 West Algonquin Road
Arlington Heights, IL 60005
847-364-7600

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated this conference

CME Credits: 7.0*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants caring for patients with cardiovascular disease.

Program Summary:
The NACE Cardiovascular Symposium 2006 is a one day program covering recent advances in coronary artery disease risk factor management, cardiovascular imaging, pharmacological management of heart failure, and valvular heart disease. It will provide a review of cardiovascular medicine geared to practicing physicians. Nationally known faculty will present evolving issues and challenges relevant to clinical practice. The set of lectures will provide a review of established principles of cardiovascular medicine as well as present new concepts and data in this rapidly advancing field.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. Recognize the favorable benefit to risk ratio of more aggressive statin therapy including reductions in myocardial infarction, stroke, and cardiovascular death and the need to increase utilization for reductions in morbidity and mortality.
2. Recognize the definition, prevalence, clinical implications, and therapy of the metabolic syndrome. Also to be discussed is the potential of specific blockade of the endocannabinoid system in the treatment of the Metabolic syndrome.
3. Demonstrate that in the management of hypertension, achieving lower blood pressure is the most important factor to prevent cardiovascular events and review the evidence-based data for the current treatment of hypertension. Based on trial evidence a rationale will be provided for pharmacological management of patients with uncomplicated and complicated hypertension.
4. Discuss the management of Chronic Heart Failure and the evidence on which it is based.
5. Review epidemiology of anemia in heart failure and characterize cause and consequences of anemia in heart failure. Discuss the pilot studies that suggest that treatment of anemia with erythropoietic agents improves exercise capacity and clinical status, but long-term trials are needed to establish the safety and efficacy of erythropoietic agents in heart failure.
6. Recognize the important aspects in the diagnosis and management of pulmonary hypertension.
7. Summarize clinical data comparing and contrasting the drug eluting stents available in the U.S. and explain the indications and safety issues of drugeluting stents.
8. Recognize the emerging potential of CT coronary angiography in the diagnostic and prognostic assessment of CAD.

Agenda:

7:30-8:10 am		Registration, Continental Breakfast and Welcome
8:10-8:20		Welcome Remarks Jose R. Soler, MD
8:20-9:10		The Growing Evidence for Aggressive Reduction of Plasma LDL W. Virgil Brown, MD
9:10-10:10		Diagnosis and Mangement of the Metabolic Syndrome W. Virgil Brown, MD
10:10-10:30		Break
10:30-11:20		Management of Chronic Congestive Heart Failure Stuart David Katz, MD
11:20-12:10		Diagnosis and Treatment of Anemia in Heart Failure Stuart David Katz, MD
12:10-1:00		Lunch
1:00-1:50		Emerging Optimal Strategies for Prevention of Cardiovascular and Renal Events in the Hypertensive Patient Robert A. Phillips, MD
1:50-2:40		Diagnosis and Management of Pulmonary Arterial Hypertension Franck F. Rahaghi, MD
2:40-3:00		Break
3:00-4:00		Advances in PCI Alexandre Cesar Ferreira, MD
4:00-4:50		Role of Cardiac CT and CTA in the Evaluation of Coronary Disease Norbert Wilke, MD
4:50-5:00		Conference Wrap Up Jose R. Soler, MD

Faculty:
W. Virgil Brown, MD
Charles Howard Candler Professor of Internal Medicine
Director, Division of Arteriosclerosis and Lipid Metabolism
Emory University School of Medicine Atlanta, Georgia
Chief of Medicine
Atlanta Veterans Affairs Medical Center
Decatur, Georgia

Alexandre Cesar Ferreira, MD
Assistant Professor of Medicine, University of Miami
Division of Cardiology, Department of Internal Medicine,
University of Miami School of Medicine, Miami, Florida

Stuart David Katz, MD
Associate Professor of Medicine
Yale University School of Medicine
Director Yale Heart Failure and Heart Transplantation Program

Robert A. Phillips, MD, PhD, FACC, FAHA
Professor of Medicine, UMASS Medical School
Medical Director of UMASS Memorial’s Heart and Vascular Center

Franck F. Rahaghi, MD, MHS, FCCP
Director, Pulmonary Hypertension Clinic
Pulmonary and Critical Care
Cleveland Clinic Florida at Weston

Norbert Wilke, MD, FACC
Associate Professor of Radiology
Associate Professor of Medicine
Chief, Cardiovascular MR and CT
University of Florida
Jacksonville, FL

Program Chair: Jose R. Soler, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.25 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for 7 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 8.4 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Actelion, Amgen, AstraZeneca, Bristol-Myers Squibb, Cordis, sanofi-aventis, Schering-Plough.